Product Information
PROPYLTHIOURACIL 50 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.2687 per EA under NDC 62135060690. Its NADAC has been published 114 times since Jul 31, 2024.
FDA first approved this application before 1982.
Strength
50 mg/1
Manufacturer
Chartwell RX LLCNDC
62135060690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPYLTHIOURACILApproval Type
Generic (ANDA)
FDA Application
ANDA080016FDA Approved
Before 1982
On Market Since
1/1/1982
Pharmacological Classes
Price Statistics
The NADAC for PROPYLTHIOURACIL 50 MG TABLET has been published 114 times since Jul 31, 2024, and over the history we have for it it has risen 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2687 per EA |
|---|---|
| All-time high | $0.3341 (Jul 16, 2025) |
| All-time low | $0.2178 (Jul 31, 2024) |
| 52-week high | $0.3044 |
| 52-week low | $0.2646 |
| Median price | $0.2811 |
| Average price | $0.2853 |
| Largest weekly change | +25.4% (Sep 18, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jul 31, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Propylthiouracil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thyroid Hormone Synthesis Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPYLTHIOURACIL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PROPYLTHIOURACIL 50 MG TABLET, manufactured by Chartwell RX LLC, is $0.2687 per EA (NDC 62135060690), effective Sep 30, 2026.
How has the price of PROPYLTHIOURACIL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has risen 23.4%. It has been tracked across 114 weekly CMS publications since Jul 31, 2024.
What are the highest and lowest recorded NADAC prices for PROPYLTHIOURACIL 50 MG TABLET?
Since Jul 31, 2024, the NADAC for PROPYLTHIOURACIL 50 MG TABLET has ranged from a low of $0.2178 (Jul 31, 2024) to a high of $0.3341 (Jul 16, 2025), with a median of $0.2811 per EA.
Are there cheaper alternatives to PROPYLTHIOURACIL 50 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROPYLTHIOURACIL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PROPYLTHIOURACIL 50 MG TABLET?
PROPYLTHIOURACIL 50 MG TABLET (NDC 62135060690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.